Comments
Granules India Ltd., on Wednesday announced that the US FDA has approved its Abbreviated New Drug Applications (ANDA) for Ibuprofen tablets USP, 400 mg, 600 mg, and 800 mg.
"The development will further strengthen our base business and enable us to increase our product offering to our customers in USA.” said C Krishna Prasad, Chairman & Managing Director of Granules India.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.